Overcome brain disorders
with advanced
neuroscience.|
Neurophet develops medical AI solutions with expertise in the neuroscience field to help patients suffering from brain disorders.
History
Neurophet are constantly challenging and growing to explore the unknown territory of the human brain and become a pioneer in the field of medical AI solutions for brain disorders.
-
2023
05
US FDA 510(k) cleared Neurophet AQUA
03
HSA(Singapore) approved Neurophet AQUA (class B)
2022
12
HSA(Singapore) approved Neurophet SCALE PET (class B)
11
MHLW(Japan) approved Neurophet SCALE PET (class II)
10
Contract agreement with Korea Disease Control and Prevention Agency(KCDC) for brain image analysis service
10
Exclusive agreement with Clairvo in Japan (Neurophet AQUA)
09
MOU with Hallym University for research partnership
09
Collaboration agreement with School of Medicine, Nanyang Technological University in Singapore
08
US FDA 510(k) cleared Neurophet SCALE PET
04
MOU with Anymedi Solution for industrialization 3D printing medical devices
03
MHLW(Japan) approved Neurophet SCALE PET (class II)
02
MFDS(Korea) certified and launched Neurophet SCALE PET
2021
11
Series B investment by SBI investment and The Wells Investment, etc ($15M)
10
MOU with B. Braun Korea
07
MFDS(Korea) approved and launched Neurophet innk
06
MFDS(Korea) certified and launched Neurophet TMS LAB
05
MOU with Medtronic Korea for research and development partnership
03
CE MDD marked Neurophet AQUA (class IIa)
2020
11
Sales partnership with Medical Standard (Neurophet AQUA)
11
Selected as execution organization for Korea Dementia Research Center(KDRC), Ministry of Health and Welfare
08
MFDS(Korea) certified and launched Neurophet AQUA
01
Series A investment by SBI Investment, Kolon Investment, etc. ($7M)
2019
08
Distributorship agreement with BRAINBOX Ltd. (Neurophet tES LAB)
02
MFDS(Korea) certified and launched Neurophet tES LAB
2018
09
Selected for 'AI in healthcare 2018' at Global Startup Program by Philips HealthWorks
2016
12
Commercialized and transferred 'Next-generation neuro-navigation system' technology
10
Seed investment by Futureplay ($0.1M)
03
Foundation of Company
Achivement
